Abstract:We undertook a retrospective pathological study of 118 skin resection specimens from 101 patients with hidradenitis suppurativa. Follicular occlusion was identified in all the specimens, regardless of disease duration (1 month to 18 years), but was not noted in the axillary and inguinal skin of controls. We therefore regard follicular occlusion as an early and important feature in the pathogenesis of the disease. The presence of apoeccrine glands in axillary skin provided an in vivo model to directly observe t… Show more
“…In a recent review article however, Lee et al [12] presented a clinical photograph of the back of a patient with HS lesions. There are no apocrine glands in these territories, but we know that the apocrine gland is not the primary target in HS [13,14]. There are also no terminal hairs, but typical localizations (such as the intermammary folds in women) also lack terminal hairs, which do not seem to be an anatomical requisite of HS lesions.…”
Background: Hidradenitis suppurativa (HS) may be associated with face and back lesions which are considered as acne. Objective: To describe the skin lesions of a group of patients with HS. Methods: Twelve patients were selected from a series of 648 patients on the basis of their specific skin lesions. Results: The patients (mostly male) had typical hidradenitis. On their face or back they had one or several of the following skin lesions which are not seen in acne: hypertrophic rope-like bridged scars, raised plaques with multiple carbuncle-like openings or with ulcerations, ‘worm-eaten scars’ and coalescent nodules with round ulcerations. All patients had deep round scars. Several had a pilonidal cyst or large epidermal cysts. Isotretinoin had been used by 7 patients with no effect. Conclusion: Some HS patients have specific lesions of the face and back which are not acne and have to be treated differently.
“…In a recent review article however, Lee et al [12] presented a clinical photograph of the back of a patient with HS lesions. There are no apocrine glands in these territories, but we know that the apocrine gland is not the primary target in HS [13,14]. There are also no terminal hairs, but typical localizations (such as the intermammary folds in women) also lack terminal hairs, which do not seem to be an anatomical requisite of HS lesions.…”
Background: Hidradenitis suppurativa (HS) may be associated with face and back lesions which are considered as acne. Objective: To describe the skin lesions of a group of patients with HS. Methods: Twelve patients were selected from a series of 648 patients on the basis of their specific skin lesions. Results: The patients (mostly male) had typical hidradenitis. On their face or back they had one or several of the following skin lesions which are not seen in acne: hypertrophic rope-like bridged scars, raised plaques with multiple carbuncle-like openings or with ulcerations, ‘worm-eaten scars’ and coalescent nodules with round ulcerations. All patients had deep round scars. Several had a pilonidal cyst or large epidermal cysts. Isotretinoin had been used by 7 patients with no effect. Conclusion: Some HS patients have specific lesions of the face and back which are not acne and have to be treated differently.
“…15,16 Accordingly, inhibition of 5␣-reductase could improve symptoms of HS by reducing local concentrations of dihydrotestosterone at the level of the hair follicles. This would explain why other antiandrogens that act by blocking dihydrotestosterone at the receptor level more globally, such as cyproterone acetate, have not been shown to be universally effective.…”
Importance: Hidradenitis suppurativa (HS) is a chronic debilitating cutaneous disease for which there is no universally effective treatment. Patients typically present at puberty with tender subcutaneous nodules that can progress to dermal abscess formation. Antiandrogens have been used in the treatment of HS, and studies have primarily focused on adult patients.Observations: We present a case series of 3 pediatric patients with HS who were successfully treated with oral finasteride, resulting in decreased frequency and severity of disease flares with no significant adverse effects.
Conclusions and Relevance:Finasteride is a therapeutic option that provides benefit for pediatric patients with HS. Further prospective data and randomized controlled studies will provide helpful information in the management of this disease.
“…In the pathogenesis of HS, follicular plugging by keratinized squamous epithelium is believed to be an essential initial step that progresses to secondary infection and the development of abscesses and sinus tracts [12][13][14][15]. The clinical course of this type of disease tends to be chronic and recurrent in a significant portion of cases, despite various pharmacological and surgical treatments [16].…”
Our observations demonstrated that the use of CO(2) FS did not make active suppurative lesions worse, and might have a therapeutic effect on suppurative diseases and their related scars. Lasers Surg. Med. 41:550-554, 2009. (c) 2009 Wiley-Liss, Inc.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.